Dr. Zwart graduated from Ferris State University in 2019.  After completion of PGY1 Pharmacy Residency at Munson Medical Center, he joins the Cowell Infusion Pharmacy as the first Munson PGY-2 Oncology resident.  Upon completion of his residency, Colton joined Cowell Infusion Pharmacy team as a clinical pharmacist. This past spring, he became board certified in oncology. Outside of work, Colton spends time with his wife, paddle boarding, and training for triathlons.

Emily earned her Doctor of Pharmacy degree from Ferris State University, College of Pharmacy in 2012. Initially she served patients in the retail setting before transitioning to a clinical role with Alpena Regional Medical Center in 2014, where she was first introduced to oncology pharmacy. Since early 2017 she has served oncology patients with The Cancer & Hematology Centers. Emily is beyond grateful for her new role with the POEM program and the opportunity to continue expanding her oncology knowledge base while exploring new initiatives to better serve oncology patients. When not at work Emily spends time with her husband, their three energetic daughters and the family dog, exploring the outdoors, hunting or fishing. She also dedicates time to pursuing her faith and loves serving in the Kid’s Ministry at Port City Church.

Dr. Mackler received her PharmD from Drake University and completed her Residency experience in Pharmacy Practice and Oncology at the University Hospital in Cincinnati, OH. She joined Michigan Medicine in 2002 as a Clinical Oncology Pharmacist. She founded the Oncology Specialty Residency at the University of Michigan in 2003 and was the program director until 2013. She has been involved in multiple oncology quality and safety endeavors including serving as the co-lead and founding developer of the NCCN Chemotherapy Order Templates since its inception in 2006, founding pharmacist in the Cancer Center Symptom Management and Supportive Care Program at the University of Michigan 2009 – 2012, founding director of the University of Michigan Oral Chemotherapy Program in 2012 and thereafter MOQC’s Oral Oncolytic Program in 2013, and founding Course Director of the Michigan Society of Hematology Oncology (MSHO) Annual Pharmacist’s Meeting. She founded HOPA’s Quality Oversight Committee and is a HOPA Board Member At-Large from 2020-2023. Dr. Mackler’s research and practice interests focus on oncology symptom management, quality of care, equity of care, medication adherence, and patient reported outcomes.

Julie Wietzke is the Manager at the Michigan Institute for Care Management and Transformation (MICMT). In this role, Julie oversees the staff and helps guide the work of MICMT. She has a Master of Health Services Administration degree and a Master of Library Science degree, specializing in health sciences information. Julie has over 20 years of experience working in healthcare in quality improvement, clinical research, and operations. She has worked with hospitals and physician organizations across the state of Michigan on initiatives aimed at improving the quality of care. In her free time, Julie enjoys spending time with family and friends, going for walks, camping, and traveling to U.S. National Parks.

Ashley Schwartz, LMSW, is a Project Manager at the Michigan Institute for Care Management and Transformation (MICMT). Ashley provides ongoing program support by collaborating and coordinating with Physician Organizations and managing BCBSM deliverables. As a licensed social worker, Ashley has several years of experience working in various healthcare settings providing clinical and administrative support. In her free time, Ashley enjoys spending time with her family, staying active and traveling the world.

Mike is one of the first members of the Patient and Caregiver Oncology Quality Council (POQC), which was formed several years ago to provide the patient and caregiver voice for MOQC. He is a member of the MOQC Steering Committee, the Measures Committee, and the PROMOnc Steering Committee which is a national effort that MOQC is partnering with to develop, test, and improve patient-reported outcomes. He was diagnosed with bladder cancer nine years ago and remains cancer-free. Mike has also been a member of the Patient and Family Advisory Committee for the Rogel Cancer Center at Michigan Medicine for the past six years and retired in 2016 after 29 years at Michigan Medicine, primarily as director of PR and Marketing as well as a manager in strategic planning.